Company: PTHS
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001753926-25-000503
Chunk: 1461

Company: Pelthos Therapeutics Inc.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 7A
Chunk 1461
---

exhibits listed in the accompanying index to exhibits are filed with this Report or incorporated by reference into this Item 15(a)(3)
as part of this Report.

(b)
The following are exhibits to this Report and, if incorporated by reference, we have indicated the document previously filed with
the SEC in which the exhibit was included.

Certain
of the agreements filed as exhibits to this Report contain representations and warranties by the parties to the agreements that
have been made solely for the benefit of such parties. These representations and warranties:

    ●
    may have been qualified
    by disclosures that were made to the other parties in connection with the negotiation of the agreements, which disclosures
    are not necessarily reflected in the agreements;

    ●
    may apply standards
    of materiality that differ from those of a reasonable investor; and

    ●
    were made only as
    of specified dates contained in the agreements and are subject to subsequent developments and changed circumstances.

103 

Accordingly,
these representations and warranties may not describe the actual state of affairs as of the date that these representations and
warranties were made or at any other time. Investors should not rely on them as statements of fact.

    Exhibit
    No.
     
    Description
    of Exhibit 

    2.1
     
    Contribution
    Agreement (filed as Exhibit 2.1 to Registrant’s Registration Statement on Form S-1/A, filed with the SEC on January
    20, 2023 and incorporated by reference herein).

    2.2
     
    Side
    Letter to Contribution Agreement (filed as Exhibit 2.2 to Registrant’s Registration Statement on Form S-1/A, filed with
    the SEC on September 1, 2023 and incorporated by reference herein).

    3.1
     
    Amended
    and Restated Certificate of Incorporation (filed as Exhibit 3.1 to Registrant’s Current Report on Form 8-K, filed with
    the SEC on February 22, 2024 and incorporated by reference herein).

    3.2
     
    Certificate
    of Designation of Series A Convertible Preferred Stock, as currently in effect (filed as Exhibit 3.2 to Registrant’s
    Registration Statement on Form S-1/A, filed with the SEC on January 20, 2023 and incorporated by reference herein).

    3.3